SCHEMBL8077207

SCHEMBL8077207

CCCCCCCC=Cn1c(=O)ccn(C)c1=O

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MGLL Q99685 3/20 0.44
FAAH O00519 4/20 0.40
SOAT2 O75908 1/20 0.36
SOAT1 P35610 1/20 0.36
TRPV1 Q8NER1 1/20 0.36
CNR2 P34972 2/20 0.36
ALDH1A1 P00352 1/20 0.36
TP53 P04637 1/20 0.36
HSP90AA1 P07900 1/20 0.36
CYP3A4 P08684 1/20 0.36
G6PD P11413 1/20 0.36
HPGD P15428 1/20 0.36
ALOX15 P16050 1/20 0.36
TSHR P16473 1/20 0.36
HIF1A Q16665 1/20 0.36
HSD17B10 Q99714 1/20 0.36
PSMB11 A5LHX3 2/20 0.35
PSMA7 O14818 2/20 0.35
PSMB1 P20618 2/20 0.35
PSMA1 P25786 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8070636 0.94 MGLL (0.36) MGLLFAAHCNR2ALDH1A1TP53
SCHEMBL8070629 0.94 MGLL (0.36) MGLLFAAHCNR2ALDH1A1TP53
SCHEMBL8435245 0.75 MGLL (0.43) MGLLFAAHSOAT2SOAT1TRPV1
SCHEMBL31544335 0.71 SOAT2 (0.44) MGLLFAAHSOAT2SOAT1TRPV1
SCHEMBL31544333 0.71 SOAT2 (0.44) MGLLFAAHSOAT2SOAT1TRPV1
SCHEMBL8431320 0.71 MGLL (0.41) MGLLFAAHCNR2ALDH1A1CYP3A4
SCHEMBL2543005 0.69 MGLL (0.39) MGLLFAAHTRPV1ALDH1A1ALOX15
SCHEMBL9242254 0.69 ALDH1A1 (0.42) MGLLFAAHALDH1A1TP53HSP90AA1
SCHEMBL31544325 0.69 SOAT2 (0.42) MGLLFAAHSOAT2SOAT1TRPV1
SCHEMBL31544326 0.69 MGLL (0.42) MGLLFAAHSOAT2SOAT1TRPV1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6121270-A N-(EPOXYALKYL)XANTHINE DERIVATIVES WHICH MODULATE CELLULAR RESPONSES TO NOXIOUS, PRO-INFLAMMATORY STIMULI CELL THERAPEUTICS, INC. (US) 2000-09-19 US disclosed
US-5866576-A COMPOUNDS THAT ACT AS DRUGS ON THE CELLULAR AND BIOCHEMICAL LEVEL TO MODULATE CELLULAR RESPONSES TO NOXIOUS, PRO-INFLAMMATORY STIMULI. CELL THERAPEUTICS, INC. (US) 1999-02-02 US disclosed
US-5859017-A PREVENTING OR TREATING ALLERGIES; INHIBITING INTRACELLULAR GENERATION OF PHOSPHATIDIC ACID AND DIACYLGLYCEROL CELL THERAPEUTICS, INC. (US) 1999-01-12 US disclosed
US-5670506-A ANTIINFLAMMATORY AGENTS, FUNGICIDES, MICROBIOCIDES CELL THERAPEUTICS, INC. (US) 1997-09-23 US disclosed
EP-0714302-A4 THERAPEUTIC COMPOUNDS CELL THERAPEUTICS INC (US) 1996-10-09 EP disclosed
EP-0714302-A1 THERAPEUTIC COMPOUNDS CELL THERAPEUTICS, INC. (US) 1996-06-05 EP disclosed
US-5521315-A Olefin substituted long chain compounds CELL THERAPEUTICS, INC. (US) 1996-05-28 US disclosed
EP-0662834-A4 NOVEL EPOXIDE-CONTAINING COMPOUNDS. CELL THERAPEUTICS INC (US) 1996-04-17 EP disclosed
EP-0697873-A4 1996-04-03 EP disclosed
EP-0697873-A1 OLEFIN-SUBSTITUTED LONG CHAIN COMPOUNDS CELL THERAPEUTICS, INC. (US) 1996-02-28 EP disclosed
EP-0662834-A1 NOVEL EPOXIDE-CONTAINING COMPOUNDS CELL THERAPEUTICS, INC. (US) 1995-07-19 EP disclosed
WO-1994022449-A1 THERAPEUTIC COMPOUNDS CELL THERAPEUTICS, INC. (US) 1994-10-13 WO disclosed
WO-1994015606-A1 OLEFIN-SUBSTITUTED LONG CHAIN COMPOUNDS CELL THERAPEUTICS, INC. (US) 1994-07-21 WO disclosed
WO-1994006431-A1 NOVEL EPOXIDE-CONTAINING COMPOUNDS CELL THERAPEUTICS, INC. (US) 1994-03-31 WO disclosed